TFEB Antibody [G16A13]

Catalog No.: F4797

    Application: Reactivity:

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:30
    1:500
    1:50
    1:500
    Application
    WB, IP, IHC, IF, FCM
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    53 kDa 70 kDa, 60 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。

    Datasheet & SDS

    生物学的記述

    Specificity
    TFEB Antibody [G16A13] detects endogenous levels of total TFEB protein.
    Clone
    G16A13
    Synonym(s)
    BHLHE35, TFEB, Transcription factor EB, Class E basic helix-loop-helix protein 35, bHLHe35
    Background
    TFEB is a basic helix–loop–helix leucine zipper transcription factor of the MiT/TFE family that functions as a master regulator of lysosomal biogenesis, autophagy, and lysosome-dependent metabolic adaptation by binding E‑box–type CLEAR motifs in promoters of lysosomal and autophagy genes as homodimers or heterodimers with TFE3 or MITF. The protein comprises an N‑terminal bHLH‑Zip DNA‑binding and dimerization module and a C‑terminal transactivation region that recruits co‑activators, and its activity is controlled primarily through phosphorylation-dependent cytoplasmic retention versus nuclear import. Under nutrient‑replete conditions, TFEB is phosphorylated on key serines by mTORC1 at the lysosomal surface and by additional kinases, including GSK3β and ERK, creating docking sites for 14‑3‑3 proteins and confining TFEB to the cytosol or lysosomal membrane, which keeps CLEAR-driven transcription low. Starvation or lysosomal stress reduces mTORC1 activity and promotes calcineurin-dependent dephosphorylation of TFEB, leading to release from 14‑3‑3, nuclear translocation, and robust occupancy of CLEAR elements such as 5′‑GTCACGTGAC‑3′ in promoters of lysosomal hydrolases, membrane proteins, and autophagy factors, with coordinated upregulation of both lysosomal and autophagosome genes. This transcriptional switch expands lysosomal mass, increases autophagic flux, and adjusts lysosome positioning via induction of genes such as PIP4P1, thereby enhancing degradative capacity and recycling of amino acids, lipids, and other metabolites during nutrient limitation. TFEB also interacts with ACSS2 under glucose deprivation, providing local acetyl‑CoA for histone acetylation at TFEB target loci and strengthening expression of lysosome and autophagy genes, linking TFEB‑dependent catabolic gene activation to chromatin remodeling at its own binding sites. In innate immune responses to bacterial infection, lipopolysaccharide stimulation induces IRG1-dependent production of itaconate, which directly alkylates a conserved cysteine within TFEB, reduces mTOR‑mediated phosphorylation, promotes nuclear accumulation, and activates a TFEB program of lysosomal biogenesis in macrophages; genetic or biochemical disruption of this itaconate–TFEB axis impairs bacterial clearance, whereas preserving TFEB alkylation enhances antibacterial capacity.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください